RecruitingNCT05521451

Clinical Cohort Study - TRUST

Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

5,000 participants

Start Date

Mar 17, 2021

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Supraventricular Tachycardia Atrial Flutter Ventricular Tachycardia Atrial Tachycardia Torsades de Pointes Arrhythmogenic Right Ventricular Dysplasia Long QT Syndrome Brugada Syndrome Catecholaminergic Polymorphic Ventricular Tachycardia Atrial Cardiomyopathy

Summary

The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia
Age ≥ 18 years
Written informed consent
Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation

Exclusion Criteria2

Insufficient knowledge of the German language to understand study documents and interview without translation
Physical or psychological incapability to cooperate in the investigation